Anti-inflammatory mechanisms

"Anti-inflammatory mechanisms" is not a single molecule or receptor but rather refers to the diverse biological processes and molecular pathways that reduce or resolve inflammation in tissues. These mechanisms involve multiple targets—including cytokines (such as interleukin‑10 and transforming growth factor-beta), transcription factors (like NF-kB), cell surface receptors (such as Toll-like receptor 4), intracellular signaling cascades (MAPK pathway), antioxidant systems (thioredoxin induction by SOCS1), nuclear hormone receptors (PPARα)—and their coordinated regulation determines the balance between pro-inflammatory and anti-inflammatory responses. Drugs with anti-inflammatory properties may act at one or more points within these networks to inhibit inflammatory mediator production or promote resolution signals. Because "anti-inflammatory mechanisms" is an umbrella term describing functional outcomes across many targets rather than a discrete therapeutic target itself, it should not be considered a canonical drug target.[1][2][3][4]

Mechanisms include inhibition of pro-inflammatory cytokine production, suppression of transcription factors like NF-kB and AP1, upregulation of anti-inflammatory mediators such as IL‑10 and TGF‑β, antioxidant effects via ROS scavenging proteins like thioredoxin.[1][2][3][4]